Abstract: The present disclosure is grounded in field study of habits of many species of animals, such as birds and bats to provide some examples, as well as their anatomical composition. This study has allowed an understanding of ingrained responses of these animals that can be modified by a biological understanding of physiology, sound and ultrasound technology, laser technology, and intelligent animal recognition. The unique coordination between these specialized technologies provides for animal casualty prevention in a sustainable way that achieves unprecedented success in diverting or deterring animals from their collision course with objects, such as wind turbines or aircraft to provide some examples. Moreover, the present disclosure does not substantially affect the well-being of the animals and does not introduce substantially harmful side-effects to the animals, their environment, and any surrounding human population.

Abstract: The present disclosure is grounded in field study of habits of many species of animals, such as birds and bats to provide some examples, as well as their anatomical composition. This study has allowed an understanding of ingrained responses of these animals that can be modified by a biological understanding of physiology, sound and ultrasound technology, laser technology, and intelligent animal recognition. The unique coordination between these specialized technologies provides for animal casualty prevention in a sustainable way that achieves unprecedented success in diverting or deterring animals from their collision course with objects, such as wind turbines or aircraft to provide some examples. Moreover, the present disclosure does not substantially affect the well-being of the animals and does not introduce substantially harmful side-effects to the animals, their environment, and any surrounding human population.

Abstract: The invention provides compositions, vaccine compositions and pharmaceutical compositions for the treatment, amelioration and/or prevention of dengue fever. The compositions, vaccine compositions and pharmaceutical compositions of the invention comprise a virus-like particle of an RNA bacteriophage and at least one antigen, wherein said at least one antigen is a dengue antigen. When administered to an animal, preferably to a human, said compositions, vaccine compositions and pharmaceutical compositions induce efficient immune responses, in particular antibody responses, wherein typically and preferably said antibody responses are directed against dengue virus, preferably against dengue virus of any one of serotypes 1 to 4. Thus, the invention further provides methods of treating, ameliorating and/or preventing dengue virus infection by way of active immunization against domain III of the dengue virus envelope protein E, or against antigenic fragments thereof.

Abstract: The present invention relates to nucleic acid molecules and in particular to vectors, comprising at least one gene of interest, at least one scaffold/matrix attached region (S/MAR), at least one origin of replication, and at least one replication initiation factor, cells comprising these, processes for their propagation, and their use, in particular for the high level expression of proteins which can be used as medicaments.

Abstract: The present invention relates to compositions and methods that allow the production of polypeptides and untranslated RNA molecules in host cells. More specifically, the invention provides nucleic acid molecules, expression systems, recombinant host cells, methods and kits, which enable the production and/or isolation and/or purification of polypeptides and untranslated RNA molecules. The compositions and methods of the invention can be applied in a regulatable expression system that is transiently transfected into mammalian host cells.

Abstract: The present invention relates to nucleic acid molecules and in particular to vectors, comprising at least one gene of interest, at least one scaffold/matrix attached region (S/MAR), at least one origin of replication, and at least one replication initiation factor, cells comprising these, processes for their propagation, and their use, in particular for the high level expression of proteins which can be used as medicaments.